Seguir
Sima Rafati
Sima Rafati
E-mail confirmado em pasteur.ac.ir
Título
Citado por
Citado por
Ano
Improvement of different vaccine delivery systems for cancer therapy
A Bolhassani, S Safaiyan, S Rafati
Molecular cancer 10, 1-20, 2011
3822011
Leishmaniasis vaccine candidates for development: a global overview
A Khamesipour, S Rafati, N Davoudi, F Maboudi, F Modabber
Indian Journal of Medical Research 123 (3), 423, 2006
2682006
Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis
A Salhi, V Rodrigues, F Santoro, H Dessein, A Romano, LR Castellano, ...
The Journal of Immunology 180 (9), 6139-6148, 2008
2042008
Heat-shock proteins as powerful weapons in vaccine development
A Bolhassani, S Rafati
Expert review of vaccines 7 (8), 1185-1199, 2008
1842008
Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum
S Rafati, A Nakhaee, T Taheri, Y Taslimi, H Darabi, D Eravani, S Sanos, ...
Vaccine 23 (28), 3716-3725, 2005
1712005
A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major
S Rafati, AH Salmanian, T Taheri, M Vafa, N Fasel
Vaccine 19 (25-26), 3369-3375, 2001
1412001
Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis
A Mizbani, T Taheri, F Zahedifard, Y Taslimi, H Azizi, K Azadmanesh, ...
Vaccine 28 (1), 53-62, 2009
1222009
Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis
S Rafati, F Zahedifard, F Nazgouee
Vaccine 24 (12), 2169-2175, 2006
1142006
Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies
A Bolhassani, T Taheri, Y Taslimi, S Zamanilui, F Zahedifard, N Seyed, ...
Experimental parasitology 127 (3), 637-645, 2011
1082011
CD8+ T cells in Leishmania infections: friends or foes?
S Stager, S Rafati
Frontiers in immunology 3, 20609, 2012
1072012
Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice
M Golkar, MA Shokrgozar, S Rafati, K Musset, M Assmar, R Sadaie, ...
Vaccine 25 (21), 4301-4311, 2007
1042007
Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157: H7
J Amani, AH Salmanian, S Rafati, SL Mousavi
Vaccine 28 (42), 6923-6929, 2010
972010
Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies
A Bolhassani, F Zahedifard, M Taghikhani, S Rafati
Vaccine 26 (26), 3362-3370, 2008
932008
Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection
D Doroud, F Zahedifard, A Vatanara, AR Najafabadi, Y Taslimi, ...
Journal of controlled release 153 (2), 154-162, 2011
912011
Leishmaniasis and various immunotherapeutic approaches
Y Taslimi, F Zahedifard, S Rafati
Parasitology 145 (4), 497-507, 2018
902018
Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis
A Zadeh-Vakili, T Taheri, Y Taslimi, F Doustdari, AH Salmanian, S Rafati
Vaccine 22 (15-16), 1930-1940, 2004
812004
Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen
F Zahedifard, E Gholami, T Taheri, Y Taslimi, F Doustdari, N Seyed, ...
PLoS neglected tropical diseases 8 (3), e2751, 2014
792014
Immunogenicity of a plant-derived edible chimeric EspA, Intimin and Tir of Escherichia coli O157: H7 in mice
J Amani, SL Mousavi, S Rafati, AH Salmanian
Plant science 180 (4), 620-627, 2011
792011
Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis
N Saljoughian, T Taheri, F Zahedifard, Y Taslimi, F Doustdari, ...
PLoS neglected tropical diseases 7 (4), e2174, 2013
742013
Cationic solid lipid nanoparticles loaded by cystein proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluations
D Doroud, A Vatanara, F Zahedifard, E Gholami, R Vahabpour, ...
Journal of Pharmacy & Pharmaceutical Sciences 13 (3), 320-335, 2010
742010
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20